| 名称 | Asenapine Maleate |
| 描述 | Asenapine Maleate (Org 5222 maleate) is a second generation (atypical) antipsychotic agent that is taken sublingually and used in the treatment of schizophrenia and manic or mixed episodes associated with bipolar 1 disorder. Asenapine is associated with a low rate of transient and mild serum aminotransferase elevations during therapy but has not been linked to instances of clinically apparent acute liver injury. |
| 激酶实验 | In vitro kinase activity: GST-FAK in vitro kinase activity is measured and compared to His-tagged FAK 411–686 using the K-LISA screening kit and poly(Glu:Tyr) (4:1) copolymer as a substrate immobilized on microtiter plates. IC50 values are determined with various concentrations of test compounds in a buffer containing 50 μM ATP and 10 mM MnCl2, 50 mM HEPES (pH 7.5), 25 mM NaCl, 0.01% BSA, and 0.1 mM Na orthovanadate for 5 min at room temperature. Serial diluted compounds are tested in triplicate. Substrate phosphorylation is measured using horseradish peroxidase-conjugated anti-pTyr antibodies with spetrophotometric color quantitation. IC50 values are determined using the Hill-Slope Model. Kinase selectivity profiling is performed by using the KinaseProfiler service. |
| 体外活性 | Asenapine（0.01 mg/kg,i.v.）与NAc核相比,壳内优先增加多巴胺的流出量,而高剂量(0.05 mg/kg, i.v.)则无差异.在内侧前额叶皮质的锥体细胞中,Asenapine对NMDA诱导的应答有显著增强作用.在自由移动的大鼠中,Asenapine（0.05-0.2 mg/kg,皮下注射）诱导剂量依赖性CAR抑制（无逃避失败记录）,且未诱发强直性昏厥.在大鼠在内侧前额叶皮质和伏隔核中,Asenapine（0.05-0.2 mg/kg,皮下注射）同时增加多巴胺流出. |
| 体内活性 | 相对于其D2受体亲和力,Asenapine对5-HT 2C,5-HT 2A,5-HT 2B,5-HT 7,5-HT 6,alpha2B和D3受体的亲和力更高,说明在治疗剂量下其与这些靶标联系更紧密。Asenapine是一种对5-HT 1A（7.4）,5-HT1B（8.1）,5-HT 2A（9.0）,5-HT 2B（9.3）,5-HT 2C（9.0）,5-HT 6（8.0 ）,5-HT 7（8.5）,D2（9.1）,D3（9.1）,alpha2A（7.3）,alpha2B（8.3）,alpha2C（6.8）和H 1受体（8.4）有效的拮抗剂（pKB）。 |
| 存储条件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | H2O : < 1 mg/mL (insoluble or slightly soluble)
10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (4.98 mM), Sonication is recommended.
DMSO : 60 mg/mL (149.31 mM), Sonication is recommended.
Ethanol : < 1 mg/mL (insoluble or slightly soluble)
|
| 关键字 | Serotonin Receptor | Org-5222 | Org5222 | Org 5222 Maleate | Inhibitor | inhibit | Asenapine Maleate | Asenapine | 5-hydroxytryptamine Receptor | 5HTReceptor | 5-HT7 | 5-HT6 | 5-HT2C | 5-HT2B | 5-HT2A | 5-HT Receptor | 5HT Receptor |
| 相关产品 | Cefaclor monohydrate | Tryptamine hydrochloride | pCPA methyl ester hydrochloride | Sevoflurane | Cloperastine hydrochloride | Venlafaxine hydrochloride | Alverine citrate | Dapoxetine hydrochloride | Mianserin hydrochloride | Trazodone hydrochloride | Clozapine N-Oxide | 1,8-Cineole |
| 相关库 | 抑制剂库 | 抗癌上市药物库 | 已知活性化合物库 | EMA 上市药物库 | FDA 上市药物库 | GPCR靶点分子库 | 神经退行性疾病化合物库 | 膜蛋白靶向化合物库 | 疼痛相关化合物库 | 药物功能重定位化合物库 | 抗癌临床化合物库 | 抗癌药物库 |